Last Price
0.004
Today's Change
0.00 (0.00%)
Day's Change
0.004 - 0.005
Trading Volume
328,140
Market Cap
12 Million
Shares Outstanding
3 Billion
Avg Volume
4,572,039
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.00
PE Ratio
0.00
EPS
0.00
Earnings Announcement
29-Feb-2024
Previous Close
0.00
Open
0.01
Day's Range
0.004 - 0.005
Year Range
0.003 - 0.009
Trading Volume
328,140
1 Day Change
0.00%
5 Day Change
-20.00%
1 Month Change
0.00%
3 Month Change
33.33%
6 Month Change
0.00%
Ytd Change
33.33%
1 Year Change
-20.00%
3 Year Change
-80.00%
5 Year Change
14.29%
10 Year Change
-95.29%
Max Change
-96.59%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.